艾滋病抗病毒治疗新药绥美凯国内有吗

Also called Dolutegra, it is a drug used to treat infection with human immunodeficiency virus (HIV). It is not only suitable for adults, but also for teenagers over 12 years old (weight greater than 40KG). It was approved for marketing by the US FDA on August 27, 2014. Due to its remarkable therapeutic effect, it has been recommended by many authoritative academic institutions and authoritative guidelines in Europe and the United States as the first-line first-line treatment for patients with HIV infection.

Suimeikai has been approved for marketing in more than 50 countries or regions around the world. For domestic patients, everyone is also concerned about whether Suimeikai, a new HIV antiviral treatment drug, is available in China?

On January 22, 2018, GlaxoSmithKline (GSK) announced that its new drug Suimeike (generic name: dolutegravir tablets) for the treatment of HIV was officially launched in mainland China. This is a single-pill compound preparation with the new generation integrase inhibitor dolutegravir (DTG) as the core. It is also the first single-pill compound preparation with a complete treatment plan in the field of HIV treatment in mainland China.

In clinical trials, Trimax was significantly more effective in suppressing viruses and had fewer side effects, rarely leading to discontinuation of treatment. Moreover, Suimeikai is an oral tablet, which is easy to use, reducing the patient's medication burden and improving the patient's compliance. The method of use of Suimeikai is to take one tablet orally once a day. If the patient weighs less than 40KG, it cannot be used because Suimeikai is a fixed dose and cannot be reduced.

It is important to note that although viral suppression with antiretroviral therapy has been shown to significantly reduce the risk of sexual transmission, residual risks cannot be ruled out. Precautions should be taken to prevent transmission in accordance with national guidance. Hypersensitivity reactions may also occur during medication. If the patient has any hypersensitivity reactions, he/she needs to stop medication immediately and adopt the correct treatment plan.

Recommended related hot articles: /newsDetail/80747.html